Adecatumumab (Anti-EpCAM / TROP1 / CD326)

Ask supplier a question | View on supplier's website

Adecatumumab (Anti-EpCAM / TROP1 / CD326) is a full human monoclonal antibody of the IgG1 isotype, targeting human EpCAM. Adecatumumab is expressed in almost all adenocarcinomas, and its activity is not dependent of K-Ras status. MW: 145.5 KD.

Supplier	Selleck Chemicals
Product #	A2512
Sku #	A2512-1mg
Pricing	1mg, $370.00

Feedback